Ann: Chairman's Address to Shareholders, page-103

Thanks whytee re the background to Circadian's present shareholding in Optiscan. Their acquisition from a now deregistered but former subsidiary makes sense, as opposed to them suddenly acquiring 8 million shares.
Still, having held since Optiscan's inception (either through a subsidiary or directly) you would think that they must have some plans for their investment, or do they just let it sit and see what happens? Probably like many of us present shareholders who have been beaten into submission and don't see any point in selling up lest we may miss out on something.
MM